Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:07 AM UTC
| NCT Number | NCT05561387 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 510 participants |
| Active Locations | 397 sites in the US |
| Sponsor | SWOG Cancer Research Network |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 18, 2026: Clinical trial NCT05561387 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 397 locations across the United States. The study is sponsored by SWOG Cancer Research Network. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05561387 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 397 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05561387 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.